[1]
Battino M, Giampieri F, Pistollato F, et al. Nrf2 as regulator of innate immunity: A molecular Swiss army knife! Biotechnol Adv 2017.
[http://dx.doi.org/10.1016/j.biotechadv.2017.12.012]
[http://dx.doi.org/10.1016/j.biotechadv.2017.12.012]
[2]
Amata E, Rescifina A, Prezzavento O, et al. (+)-Methyl (1R,2S)-2-{[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]methyl}-1-phenylcyclopropanecarboxylate [(+)-MR200] Derivatives as Potent and Selective Sigma Receptor Ligands: Stereochemistry and Pharmacological Properties. J Med Chem 2018; 61(1): 372-84.
[3]
Amata E, Dichiara M, Arena E, et al. Novel Sigma Receptor Ligand-Nitric Oxide Photodonors: Molecular Hybrids for Double-Targeted Antiproliferative Effect. J Med Chem 2017; 60(23): 9531-44.
[4]
Pittalà V, Fidilio A, Lazzara F, et al. Effects of novel nitric oxide-releasing molecules against oxidative stress in retinal pigmented epithelial cells. Oxid. Med. Cell. Long. 2017; 1420892.
[5]
Amata E, Pittalà V, Salerno L, Marrazzo A, Prezzavento O, Dichiara M. Recent advances in drug discovery of phototherapeutic non-porphyrinic anticancer agents. Eur J Med Chem 2017; 142: 459-85.
[6]
Floresta G, Rescifina A, Marrazzo A, et al. Hyphenated 3D-QSAR statistical model-scaffold hopping analysis for the identification of potentially potent and selective sigma-2 receptor ligands. Eur J Med Chem 2017; 139: 884-91.
[7]
Salerno L, Romeo G, Modica MN, et al. Heme Oxygenase- 1: a New Druggable Target in the Management of Chronic and Acute Myeloid Leukemia. Eur J Med Chem 2017; 142: 163-78.
[8]
Amata E, Marrazzo A, Dichiara M, et al. Heme Oxygenase Database (HemeOxDB) and analysis of isoform 1 inhibitors. ChemMedChem 2017; 12(22): 1873-81.